Research Blends
Wolverine Blend
BPC-157 + TB-500
- 20mg
$100.00
ViewMULTI-COMPOUND FORMULATIONS
Research Blends
Research blends combine two or more research compounds in a single lyophilized vial. For laboratory work that involves several compounds, one vial means fewer handling steps and a single, consistent storage history.
For research use only. Not for human or veterinary use. Research Use Policy
About this category
Three formulations, built in layers. The BPC-157 and TB-500 blends each add to the one before it:
- Wolverine Blend: BPC-157 and TB-500, 20mg combined.
- GLOW Blend: GHK-Cu 50mg, BPC-157 10mg and TB-500 10mg, 70mg combined.
- KLOW Blend: the GLOW components plus KPV 10mg, 80mg combined.
A growth hormone secretagogue pairing. CJC-1295 without DAC + Ipamorelin combines two peptides that act through different receptor pathways, 10mg combined in one vial.
Every component is named. Blend names are memorable, but the contents should never be a mystery. Each product page lists the components, the stated quantities where specified and links to a referenced education page for every compound: BPC-157, TB-500, GHK-Cu, KPV, CJC-1295 and Ipamorelin.
Studied individually, supplied together. Each component has its own body of published research. Research on these specific combinations is limited, so our education pages describe each compound on its own terms.
All blends are sold for laboratory research use only and are not for human or veterinary use.
Education
Related reading
Compound7 min read
BPC-157: Research Overview
BPC-157 is a synthetic 15-amino-acid peptide based on a fragment of a protein described in human gastric juice. This overview covers its structure, proposed mechanisms, the largely preclinical literature and its evolving regulatory status.
Read
Compound8 min read
CJC-1295: Research Overview
CJC-1295 is a modified analog of the GHRH(1-29) fragment, originally designed with a Drug Affinity Complex (DAC) for albumin binding. This overview explains the with- and without-DAC distinction and the published research.
Read
Compound7 min read
GHK-Cu: Research Overview
GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, first described in human plasma in 1973. This overview covers its coordination chemistry, proposed mechanisms, key studies and route-specific FDA status.
Read
FAQ
Research Blends questions
Wolverine contains BPC-157 and TB-500. GLOW adds GHK-Cu to those two peptides. KLOW contains everything in GLOW plus KPV.
CJC-1295 without DAC and Ipamorelin, 10mg combined in a single lyophilized vial. CJC-1295 acts at the GHRH receptor and Ipamorelin at the ghrelin receptor. Our Growth Hormone Secretagogues guide compares the two classes.
A blend supplies several compounds in one vial, which simplifies handling for laboratory work that uses all of them. Researchers who need independent control over each compound may prefer single-compound materials.
Our BPC-157 vs TB-500 guide compares the structure and research history of the two peptides found in the Wolverine, GLOW and KLOW blends.
No. All blends are sold for laboratory research only and are not for human or veterinary use.
A&A Wellness
Every component, clearly listed
Compare all research products, strengths and specifications.
